Neuropharmacologic aspects of apoptosis: Significance for neurodegenerative diseases

Clinical Neuropharmacology

Volumn 22, Issue 3, 1999, Pages 137-150

  Michel, Patrick P ^a,b   Lambeng, Nathalie ^a   Ruberg, Merle ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Apoptosis; Neurodegenerative diseases; Neuronal death; Neuroprotection

Indexed keywords

CASPASE; CASPASE INHIBITOR; CERAMIDE; MIMOSINE; NITRIC OXIDE; OLOMOUCINE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; ROSCOVITINE;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; GENE MUTATION; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ASTROCYTES; CALCIUM; CASPASES; CERAMIDES; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEURONS; NITRIC OXIDE; ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 0033432654     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (296)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
2. Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986;44:817-29.
3. Ellis RE, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol 1991;7:663-98.
4. Bergeron L, Yuan J. Sealing one's fate: control of cell death in neurons. Curr Opin Neurobiol 1998;8:55-63.
5. Stefanis L, Burke RE, Greene LA. Apoptosis in neurodegenerative disorders. Curr Opin Neurol 1997;10:299-305.
6. Anglade P, Vyas S, Javoy-Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol 1997;12:25-31.
7. Clark RS, Chen J, Watkins SC, et al. Apoptosis-suppressor gene Bcl-2 expression after traumatic brain injury in rats. J Neurosci 1997;17:9172-82.
8. Tompkins MM, Basgall EJ, Zamrini E, Hill WD, et al. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol 1997;150:119-31.
9. Dragunow M, Faull RL, Lawlor P, et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 1995;6:1053-7.
10. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE. Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J Neurosci 1995;15:3775-87.
11. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995; 133:225-30.
12. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 1995; 133:265-72.
13. Anderson AJ, Su JH, Cotman CW. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 1996;16:1710-19.
14. Mochizuki H, Goto K, Mori H, Mizuno Y. Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci 1996;137: 120-3.
15. Troncoso JC, Sukhov RR, Kawas CH, Koliatsos VE. In situ labeling of dying cortical neurons in normal aging and in Alzheimer's disease: correlations with senile plaques and disease progression. J Neuropathol Exp Neurol 1996;55:1134-42.
16. Sugaya K, Reeves M, McKinney M. Topographic associations between DNA fragmentation and Alzheimer's disease neuropathology in the hippocampus. Neurochem Int 1997;31:275-81.
17. Guglielmo MA, Chan PT, Cortez S et al. The temporal profile and morphologic features of neuronal death in human stroke resemble those observed in experimental forebrain ischemia: the potential role of apoptosis. Neurol Res 1998;20:283-96.
18. Migheli A, Cavalla P, Marino S, Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol 1994;53:606-16.
19. Kosel S, Egensperger R, von Eitzen U, Mehraein P, Graeber MB. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathol (Berl) 1997;93:105-8.
20. Lucassen PJ, Chung WC, Kamphorst W, Swaab DF. DNA damage distribution in the human brain as shown by in situ end labeling: area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol 1997; 56:887-900.
21. Banati RB, Aniel SE, Blunt SB. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord 1998;13:221-7.
22. Savitz SI, Rosenbaum DM. Apoptosis in neurological disease. Neurosurgery 1998;42:555-72.
23. Pettman B, Henderson CE. Neuronal cell death. Neuron 1998;20: 633-47.
24. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1-beta-converting enzyme. Cell 1993;75:641-52.
25. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene Bcl-2. Cell 1994;76:665-76.
26. Vaux DL. CED-4 - the third horseman of apoptosis. Cell 1997;90: 389-90.
27. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-20.
28. Lincz LF. Deciphering the apoptotic pathway: all roads lead to death. Immunol Cell Biol 1998;76:1-19.
29. Mignotte B, Vayssiere JL. Mitochondria and apoptosis. Eur J Biochem 1998;252:1-15.
30. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16.
31. Mignon A, Rouquet N, Joulin V. Les caspases, les protéases à cystéine de l'apoptose: un enjeu thérapeutique pour demain. Médicine/Science 1998;14:9-17.
32. Schwartz LM, Milligan CE. Cold thoughts of death: the role of ICE proteases in neuronal cell death. Trends Neurosci 1996;19:555-62.
33. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
34. Porter AG, Ng P, Janicke RU. Death substrates come alive. Bioessays 1997;19:501-7.
35. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE(MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 1997;27:1207-12.
36. Desjardins P, Ledoux S. Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex. Neurosci Lett 1998;244: 69-72.
37. Hartmann A, Hunot S, Mouatt-Prigent A, et al. FADD/MORT1 and caspase-8 are expressed in the adult human substantia nigra [abstract]. Mov Disord 1998;13(suppl 2):87.
38. Cosi C, Suzuki H, Skaper SD, et al. Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agents. Ann N Y Acad Sci 1997;825:366-79.
39. Jeggo PA. DNA repair: PARP - another guardian angel? Curr Biol 1998;8:49-51.
40. Cosi C, Colpaert F, Koek W, Degryse A, Marien M. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res 1996;729:264-69.
41. Eliasson MJ, Sampei K, Mandir AS, et al. Poly(ADP)ribose polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997;3:1089-5.
42. Goldberg YP, Nicholson DW, Rasper DM et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Gen 1996;13:442-9.
43. Kim TW, Tanzi RE. Presenilins and Alzheimer's disease. Curr Opin Neurobiol 1997;7:683-8.
44. Livingston DJ. In vitro and in vivo studies of ICE inhibitors. J Cell Biochem 1997;64:19-26.
45. Wallach D. Apoptosis: placing death under control [letter]. Nature 1997;388:123.
46. Tschoop J, Thome M, Hofmann K, Mein PE. The fight of viruses against apoptosis. Curr Opin Genet Dev 1998;8:82-7.
47. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997;22:299-306.
48. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17:2215-23.
49. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997;388: 300-4.
50. Xu DG, Crocker SJ, Doucet J-P, et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 1997;3:997-1005.
51. Roy N, McLean MD, Besner-Johnston A et al. Refined physical map of the spinal muscular atrophy gene (SMA) region at 5q13 based on YAC cosmid contiguous arrays. Genomics 1995;26:451-60.
52. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptotic gene survivin, expressed in cancer and lymphoma. Nat Med 1997;3: 917-21.
53. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998;273:32608-13
54. Chen J, Nagayama T, Jin K, et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998;18:4914-28.
55. Hartfield PJ, Bilney AJ, Murray AW. Neurotrophic factors prevent ceramide-induced apoptosis downstream of c-Jun N-terminal kinase activation in PC12 cells. J Neurochem 1998;71:161-9.
56. Kermer P, Klocker N, Labes M, Bahr M. Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci 1998;18:4656-62.
57. Martinou I, Missotten M, Fernandez PA, Sadoul R, Martinou JC. Bax and Bak proteins require caspase activity to trigger apoptosis in sympathetic neurons. Neuroreport 1998;9:15-9.
58. Nath R, Probert A Jr, McGinnis KM, Wang KK. Evidence for activation of caspase-3-like protease in excitotoxin-and hypoxia/ hypoglycemia-injured neurons. J Neurochem 1998;71:186-95.
59. Miller TM, Moulder KL, Knudson CM, et al. Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J Cell Biol 1997;139:205-17.
60. D'Mello SR, Aglieco F, Roberts MR, Borodezt K, Haycock JW. A DEVD-inhibited caspase other than CPP32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by K+ deprivation. J Neurochem 1998;70:1809-18.
61. Tanaka M, Sawada M, Miura M, Marunouchi T. Insulin-like growth factor-1 analogue prevents apoptosis mediated through an interleukin-1-beta converting enzyme (caspase-1)-like protease of cerebellar external granular layer neurons: developmental stage-specific mechanisms of neuronal death. Neuroscience 1998;84: 89-100.
62. Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94:2007-12.
63. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997;20:245-67.
64. Newton K and Strasser A. The Bcl-2 family and cell death regulation. Curr Opin Gen Dev 1998;8:68-75.
65. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997;387:773-7.
66. Wang HG, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996;87:629-38.
67. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 1997;275:1122-6.
68. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51.
69. Memon SA, Moreno MB, Petrak D, Zacharchuk CM. Bcl-2 blocks glucocorticoid-but not Fas-or activation-induced apoptosis in a T cell hybridoma. Immunology 1995;155:4644-52.
70. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995;14:6136-47.
71. Furukawa K, Estus S, Fu W, Mark RJ, Mattson MP. Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways. J Cell Biol 1997;136:1137-49.
72. Deckwerth TL, Johnson EM Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol 1993;123:1207-22.
73. Offen D, Beart PM, Cheung NS, et al. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc Natl Acad Sci USA 1998;95:5789-994.
74. Sagot Y, Dubois-Dauphin M, Tan SA, et al. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci 1995; 15:7727-33.
75. Martinou JC, Dubois-Dauphin M, Staple JK, et al. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994;13:1017-30.
76. Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 1997;390: 413-7.
77. Mogi M, Harada M, Kondo T, et al. Bcl-2 protein is increased in the brain from parkinsonian patients. Neurosci Lett 1996;215: 137-9.
78. Satou T, Cummings BJ, Cotman CW. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 1995;697:35-43.
79. Muchmore SW, Sattler M, Liang H, et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996;381:335-41.
80. Motoyama N, Wang F, Roth KA, et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 1995;267:1506-10.
81. Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD. Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 1998;18:1009-19.
82. Frankowski H, Missotten M, Fernandez PA, et al. Function and expression of the Bcl-x gene in the developing and adult nervous system. Neuroreport 1995;6:1917-21.
83. XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 1997;14:405-14.
84. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993;90:8479-83.
85. Kawanishi M. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-FAS antibody. J Virol 1997;71:3319-22.
86. Levade T, Jaffrézou J-P, Andrieu N, Laurent G. La voie sphingomyeline-céramide dans la réponse cellulaire aux effecteurs antitumoraux. Médecine/Sciences 1996;12;1219-27.
87. Spiegel S, Foster D, Kolesnick R. Signal transductionthrough lipid second messengers. Curr Opin Cell Biol 1996;8:159-67.
88. Testi R. Sphingomyelin breakdown and cell fate. Trends Biochem Sci 1996:21:468-71.
89. Haimovitz-Friedman A, Kolesnick RN, Fuks Z. Ceramide signaling in apoptosis. Br Med Bull 1997;53:539-53.
90. Pena LA, Fuks Z, Kolesnick R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 1997;53:615-21.
91. Smyth MJ, Obeid LM, Hannun YA. Ceramide: a novel lipid mediator of apoptosis. Adv Pharmacol 1997;41:133-54.
92. France-Lanord V, Brugg B, Michel PP, Agid Y, Ruberg M. Mitochondrial free radical signal in ceramide-dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease. J Neurochem 1997;69:1612-21.
93. Hunot S, Brugg B, Ricard D, et al. Nuclear translocation of NF-kB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci USA 1997;94:7531-6.
94. Baeuerle PA, Henkel T. Function and activation of NFkB in the immune system. Annu Rev Immunol 1994;12:141-79.
95. O'Neill LAJ, Kaltschmidt C. NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 1997;20: 252-8.
96. Baichwal VR, Baeuerle PA. Apoptosis: activate NF-kB or die? Curr Biol 1997;7:R94-96.
97. Boissière F, Hunot S, Faucheux B, et al. Nuclear translocation of NF-kB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport 1997;8:2849-52.
98. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer's disease. Proc Natl Acad Sci USA 1997; 94:2642-7.
99. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 1997;232:418-21.
100. Clemens JQ, Stephenson DT, Yin T, Smalstig EB, Panetta JA, Little SP. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor kappaB in rats. Stroke 1998;29:677-82.
101. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. Traumatic spinal cord injury induces nuclear factor kappaB activation. J Neurosci 1998;18:3251-60.
102. Lambeng N, Michel PP, Brugg B, Agid Y, Ruberg M. Mechanisms of apoptosis in PC12 cells irreversibly differentiated with NGF and cyclic AMP. Brain Res 1999;821:60-8.
103. Haimovitz-Friedman A, Balaban N, McLoughlin M, et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 1994;54:2591-7.
104. Zhang J, Alter N, Reed JC, Borner C, Obeid LM, Hannun YA. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 93;1996:5325-8.
105. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NFkB induced upon apoptosis. J Cell Biol 1996;134:13-23.
106. Ghafourifar P, Klein SD, Schucht O, et al. Ceramide induces cytochrome C release from isolated mitochondria: importance of mitochondrial redox state. J Biol Chem 1999;274:6080-4.
107. Li X, Song L, Jope RS. Glutathione depletion exacerbates impairment by oxidative stress of phosphoinositide hydrolysis, AP-1, and NF-kappaB activation by cholinergic stimulation. Mol Brain Res 1998;53:196-205.
108. Jin DY, Rhee SG, Jeang KT. Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem 1997;272:30952-61.
109. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci USA 1996;93:9090-5.
110. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996;274:1383-5.
111. Kalgutkar A, Crews BC, Rowlinson SW, Garner C, Seibert K, Marnett LJ. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science 1998;280:1268-70.
112. Brugg B, Michel PP, Agid Y, Ruberg M. Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem 1996;66: 733-9.
113. Mathias S, Dressler KA, Kolesnick RN. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1991;88:10009-13.
114. Lozano J, Berra E, Municio MM, et al. Protein kinase C zeta isoform is critical for kappa-B-dependent promoter activation by sphinogmyelinase. J Biochem 1994;269:19200-2.
115. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick RN. Phosphorylation of Raf by ceramide activated protein kinase. Nature 1995;378;307-10.
116. Muller G, Storz P, Bourteele S, et al. Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling. EMBO J 1998;17:732-42.
117. Wang HG, Reed JC. Mechanism of Bcl-2 protein function. Histol Histopathol 1998:13:521-30.
118. Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E. Fas-or ceramide-induced apoptosis is mediated by a Racl-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 1997;272:22173-81.
119. Herdegen T, Claret FX, Kallunki T, et al. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci 1998;18:5124-35.
120. Lannuzel A, Barnier JV, Hery C, Huynh VT, Guibert B, Gray F, Vincent JD, Tardieu M. Human immunodeficiency virus type 1 and its coat protein gp 120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol 1997;42:847-56.
121. Eilers A, Whitfield J, Babij C, Rubin LL, Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J Neurosci 1998;18:1713-24.
122. Luo Y, Umegaki H, Wang X, Abe R, Roth GS. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 1998;273:3756-64.
123. Michel PP, Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 1990; 26:428-35.
124. Virgo L, de Belleroche J. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Res 1995;676:196-204.
125. Martin G, Segui J, Diaz-Villoslada P, Montalban X, Planas AM, Ferrer I. Jun expression is found in neurons located in the vicinity of subacute plaques in patients with multiple sclerosis. Neurosci Lett 1996;212:95-8.
126. Dickens M, Rogers JS, Cavanagh J, et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 1997;277:693-6.
127. Zhou H, Summers SA, Birnbaum MJ, Pittman RN. Inhibition of Akt kinase by cell-permeable ceramide and its implication for ceramide-induced apoptosis. J Biol Chem 273,1998,16568-75.
128. Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275:661-5.
129. Crowder RJ, Freeman RS. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 1998; 18:2933-43.
130. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-41.
131. Zundel W, Giaccia A. Inhibition of the anti-apoptotic PI(3)K/Akt/ Bad pathway by stress. Genes Dev 1998;12:1941-6.
132. Krieglstein K, Henheik P, Farkas L, Jaszai J, Galter D, Krohn K, Unsicker K. Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons. J Neurosci 1998;18: 9822-34.
133. Clarkson ED, Zawada WM, Freed CR. GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell Tissue Res 1997;289:207-10.
134. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat 1996;10:179-90.
135. Schulz JB, Matthews RT, Beal MF. Role of nitric oxide in neurodegenerative diseases. Curr Opin Neurol 1995;8:480-6.
136. Schulz JB, Matthews RT, Klockgether T, Dichgans J, Beal MF. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem 1997;174:193-7.
137. Kinugawa K, Shimizu T, Yao A, Kohmoto O, Serizawa T, Takahashi T. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res 1997;81: 911-21.
138. Pahan K, Sheikh FG, Khan M, Namboodiri AM, Singh I. Sphingomyelinase and ceramide stimulate the expression inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem 1998; 273:2591-600.
139. Estevez AG, Spear N, Manuel SM, et al. Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J Neurosci 1998;18:923-31.
140. Wink DA, Hanbauer I, Grisham MB, et al. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr Top Cell Regul 1996;34:159-87.
141. Nicotera P, Brune B, Bagetta G. Nitric oxide: inducer or suppressor of apoptosis? Trends Pharmacol Sci 1997;18:189-90.
142. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1 beta-converting enzyme (ICE)-like and cysteine protease protein (CPP32)-like proteases. J Exp Med 1997;185:601-7.
143. Li J, Billiar TR, Talanian RV, Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 1997;240:419-24.
144. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature 1997; 388:432-3.
145. Tenneti L, D'Emilia DM, Lipton SA. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci Lett 1997;235: 139-42.
146. Brune B, Mohr S, Messmer UK. Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev Physiol Biochem Pharmacol 1996;127:1-30.
147. Farinelli SE, Park DS, Greene LA. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci 1996;16:2325-34.
148. Huang PL, Fishman MC. Genetic analysis of nitric oxide synthase isoforms: targeted mutation in mice. J Mol Med 1996;74:415-21.
149. Ayata C, Ayata G, Hara H, et al. Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci 1997;17:6908-17.
150. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997; 17:9157-64.
151. Vodovotz Y, Lucia MS, Flanders KC, et al. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 1996;184:1425-33.
152. Abe K, Pan LH, Watanabe M, Konno H, Kato T, Itoyama Y. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res 1997;19:124-8.
153. Hunot S, Boissière F, Faucheux B, et al. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996; 72:355-63.
154. Hunot S, Dugas N, Faucheux B, et al. Fc∈RII/CD23 is expressed in Parkinson's Disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-α in glial cells. J Neurosci 1999 (in press).
155. Chao CC, Hu S, Sheng WS, Bu D, Bukrinsky MI, Peterson PK. Cytokine stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 1996;16:276-84.
156. Weldon DT, Rogers SD, Ghilardi JR, et al. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 1998;18:2161-73.
157. Akama KT, Albanese C, Pestell RG, Van Eldik LJ. Amyloid betapeptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci USA 1998; 95:5795-800.
158. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA 1996;93:4565-71.
159. Hantraye P, Brouillet E, Ferrante R, et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 1996;2:1017-21.
160. Di Monte DA, Royland JE, Anderson A, Castagnoli K, Castagnoli N Jr, Langston JW. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity . J Neurochem 1997;69:1771-3.
161. Franklin JL, Johnson EM Jr. Elevated intracellular calcium blocks programmed neuronal death. Ann N Y Acad Sci 1994;747:195-204.
162. Schanne FA, Kane AB, Young EE, Farber JL. Calcium dependence of toxic cell death: a final common pathway. Science 1979; 206:700-2.
163. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990;13: 171-82.
164. Ankarcrona M, Dypbukt JM, Bonfoco E, et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15:961-73.
165. Orrenius S, Ankarcrona M, Nicotera P. Mechanisms of calciumrelated cell death. Adv Neurol 1996;71:137-49.
166. Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS. The GluR2 (GluR-B) hypothesis: Ca2+-permeable AMPA receptors in neurological disorders. Trends Neurosci 1997;20:464-9.
167. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998;12:773-90.
168. Oosternik BJ, Korte SM, Nyakas C, Korf J, Luiten PG. Neuroprotection against N-methyl-D-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT1A receptor agonist 8-OH-DPAT. Eur J Pharmacol 1998;358:147-52.
169. Martel JC, Chopin P, Colpaert F, Marien M. Neuroprotective effects of alpha-2-adrenoceptor antagonists, (+)-efaroxan and (±) idazoxan, against quinolinic acid-induced lesions of the rat striaturn. Exp Neurol 1998;154:595-601.
170. Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 1993;16:125-31.
171. Mouatt-Prigent A, Karlsson JO, Agid Y, Hirsch EC. Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience 1996;73:979-87.
172. Mouatt-Prigent A, Agid Y, Hirsch EC. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease? Brain Res 1994;668:62-70.
173. Vito P, Lacana E, D'Adamio L. Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996;271:521-5.
174. Hirashima N, Etcheberrigaray R, Bergamaschi S, et al. Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol Aging 1996;17:549-55.
175. Mattson MP, Barger SW, Cheng B, Liederburg I, Smith-Swintosky VL, Rydel RE. Beta-amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci 1996;16:409-14.
176. Paoletti F, Tombaccini D. Free Ca2+ levels and expresssion of biochemical markers in Alzheimer's fibroblasts. Neurabiol Aging 1997;18:261-2.
177. Sheehan JP, Swerdlow RH, Miller SW, et al. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J Neurosci 1997;17:4612-22.
178. Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J Neurochem 1997;68:1221-33.
179. Nath R, Raser KJ, Hajimohammadreza I, Wang KK. Thapsigargin induces apoptosis in SH-SY5Y neuroblastoma cells and cerebrocortical cultures. Biochem Mol Biol Int 1997;43:197-205.
180. Wei H, Bredesen DE, Perry DC. Bcl-2 protects against apoptosis in neuronal cell line caused by thapsigargine-induced depletion of intracellular calcium stores. J Neurochem 1998;70:2305-14.
181. Wei H, Perry DC. Dantrolene is cytoprotective in two models of neuronal cell death. J Neurochem 1996;67:2390-8.
182. Guo Q, Sopher BL, Furukawa K, et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. J Neurosci 1997;17:4212-22.
183. Budd SL, Nicholls DG. Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J Neurochem 1996;67:2282-91.
184. Kristian T, Siesjo BK. Calcium in ischemic cell death. Stroke 1998; 29:705-18.
185. Bruno V, Scapagnini U, Canonico PL. Excitatory amino acids and neurotoxicity. Funct Neurol 1993;8:279-2.
186. 2+ loads. J Neurophysiol 1994;72:2563-9.
187. Dessi F, Ben-Ari Y, Charriaut-Marlangue C. Ruthenium red protects against glutamate-induced neuronal death in cerebellar culture. Neurosci Lett 1995;201:53-6.
188. Reynolds IJ, Hastings TG. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 1995;33;3318-27.
189. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182:367-77.
190. Baek JH, Lee YS, Kang CH, et al. Intracellular Ca2+ release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int J Cancer 1997;73:725-8.
191. Kiedrowski L, Costa E. Glutamate induces destabilisation of intracellular calcium concentration homeostasis in cultured cerebellar granule cells: role of mitochondria in calcium buffering. Mol Pharmacol 1995;47:140-7.
192. Liu H, Bowes RC, van de Water B, Sillence C, Nagelkerke JF, Stevens JL. Endoplasmic reticulum chaperones, GRP78 and calretinin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells. J Biol Chem 1997;272:21751-9.
193. Quillet-Mary A, Jaffrézou JP, Mansat V, Bordier C, Naval J, Laurent G. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 1997;272:21388-95.
194. Richter C. Pro-oxidants and mitochondrial Ca2+: their relationship to apoptosis and oncogenesis. FEBS Lett 1993;325:104-7.
195. Simpson PB, Russell JT. Role of mitochondrial Ca2+ regulation in neuronal
196. Baffy G, Miyashsita T, Williamson JR, Reed JC. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 1993;268:6511-9.
197. Murphy AN, Bredesen DE, Cortopassi G, Wang E, Fiskum G. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci USA 1996;93:9893-8.
198. He H, Lam M, McCormick TS, Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 1997;138:1219-28.
199. Marin MC, Fernandez A, Bick RJ, et al. Apoptosis suppression by Bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene 1996;12:2259-66.
200. Beal FM. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-66.
201. Benzi G, Moretti A. Are reactive oxygen speicies involved in Alzheimer's disease? Neurobiol Aging 1995;16:661-74.
202. Gorman AM, McGowan A, O'Neill C, Cotter T. Oxidative stress and apoptosis in neurodegeneration. J Neurol Sci 1996;139 (suppl):45-52.
203. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996;47(suppl 3):161-70.
204. Schapira AH Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol 1996;9:260-64.
205. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 1996;36:83-106.
206. Ratan RR, Murphy TH, Braban JM. Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 1994;62: 376-9.
207. Troy C, Shelanski ML. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci USA 1994;91:6384-7.
208. Talley AK, Dewhurst S, Perry SW, et al. Tumor necrosis factor alpha-induced-apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes Bcl-2 and crmA. Mol Cell Biol 1995;15:2359-66.
209. Castagne V, Clarke PG. Axotomy-induced retinal ganglion cell death in development: its time-course and its diminution by anti-oxidants. Proc R Soc Lond B Biol Sci 1996;263:1193-7.
210. Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 1996;3: 129-35.
211. Atabay C, Cagnoli CM, Kharlamov E, Ikonomovic MD, Manev H. Removal of serum from primary cultures of cerebellar granule neurons induces oxidative stress and DNA fragmentation: protection with antioxidants and glutamate receptor antagonists. J Neurosci Res 1996;43:465-75.
212. Gabby M, Tauber M, Porat S, Simantov R. Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis. Neuropharmacology 1996;35:571-8.
213. Desole MS, Sciola 1, Delogu MR, Sircana S, Migheli R, Miele E. Role of oxidative stress in the manganese and 1-methyl-4-(2'ethylphenyl)-1,2,3,6-tetrahydropyridine-induced apoptosis in PC 12 cells. Neurochem Int 1997;31:169-76.
214. Ghadge GD, Bindokas VP, Jordan J, Ma L, Miller RJ, Roos RP. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanism of neuronal death and protection. J Neurosci 1997;17:8756-66.
215. Offen D, Ziv I, Barzilai A, et al. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease. Neurochem Int 1997;31:207-16.
216. Seaton TA, Cooper JM, Schapira AH. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 1997;777:110-8.
217. Jacobson MD. Reactive oxygen species and programmed cell death. Trends Biochem Sci 1996;21:83-6.
218. Susin SA, Zamzami N, Castedo M, et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J Exp Med 1997;186:25-37.
219. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 1997;272:11369-77.
220. Gudz TI, Tserng KY, Hoppel CL. Direct inhibition of mitochondrial respiratory chain complex III by cell permeable ceramide. J Biol Chem 1997;272:24154-8.
221. Kinscheref R, Claus R, Wagner M, et al. Apoptosis caused by oxidized LDL is manganese Superoxide dismutase and p53 dependent. FASEB J 1998;12:461-7.
222. Takahashi H, Hashimoto Y, Kinouchi M, Iizuka H. Interferongamma-dependent induction of managanese Superoxide dismutase activity of SV40-transformed human keratinocytes by anti-Fas antibody and by TNF-alpha. J Dermatol Sci 1998;16:191-9.
223. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosi Res 1997;49:681-97.
224. Keller JN, Kindy MS, Holtsberg FW, et al. Mitochondrial manganese Superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 1998;18:687-97.
225. Murakami K, Kondo T, Kwase M, et al. Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J Neurosci 1998;18:205-13.
226. Radunovic A, Porto WG, Zeman S, Leigh PN. Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex. Neurosci Lett 1997; 239:105-8.
227. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO. Requirement for superoxide in excitotoxic cell death. Neuron 1996;16: 345-55.
228. Dugan LL, Sensi SL, Canzoniero LM, et al. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-Methyl-D-Aspartate. J Neurosci 1995;15:6377-88.
229. Behl C. Beta-amyloid-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 1997;290:471-80.
230. Multhaup G, Ruppert T, Schlicksupp A, et al. Reactive oxygen species and Alzheimer's disease. Biochem Pharmacol 1997;54: 533-9.
231. Yim MB, Kang JH, Yim HS, Kwak HS, Chock PB, Stadtman ER. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu/Zn-superoxide dismutase mutant. An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Natl Acad Sci USA 1996;93:5709-14.
232. Qin ZH, Wang Y, Nakai M, Chase TN. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum. Mol Pharmacol 1998;53:33-42.
233. Bales KR, Du Y, Van GM, Hamilton-Byrd E, Paul SM. The NF-kappaB/Rel family of proteins mediates beta-amyloid peptide-induced neurotoxicity and glial activation. Brain Res Mol Brain Res 1998;57:63-72.
234. Koenig M, Mandel JL. Deciphering the cause of Friedreich ataxia. Curr Opin Neurobiol 1997;7:689-94.
235. Hirsch EC, Faucheux BA. Iron metabolism and Parkinson's disease. Mov Disord 1998;13(suppl 1):39-45.
236. Suzuki Y, Ono Y, Hirabayashi Y. Rapid and specific reactive oxygen species generation via NADPH oxidase activation during Fas-mediated apoptosis. FEBS Lett 199;425:209-12.
237. Tang DG, Chen YQ, Honn KV. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Natl Acad Sci USA 1996;93:5241-6.
238. O'Donnell VB, Spycher S, Azzi A. Involvement of oxidants and oxidant generating enzyme(s) in tumour-necrosis-factor-alpha-mediated apoptosis: role for lipoxygenase pathway but not mitochondrial respiratory chain. Biochem J 1995;310:133-41.
239. Yan CY, Ferrari G, Greene LA. N-acetylcysteine-promoted survival of PC12 cells is glutathione-independent but transcription-dependent. J Biol Chem 1995;270:26827-32.
240. Ferrari G, Yan CY, Greene LA. N-acetylcysteine (D-and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 1995;15:2857-66.
241. Mattson MP, Robinson N, Guo Q. Estrogens stabilise mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 1997;8:3817-21.
242. Behl C, Skutella T, Lezoualc'h F, et al. Neuroprotection against oxidative stress by estrogens: structure activity relationship. Mol Pharmacol 1997;51:535-41.
243. Green PS, Gridley KE, Simpkins JW. Nuclear estrogen receptorindependent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 1998;84:7-10.
244. Bains JS, Shaw CA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev 1997;25:335-58.
245. Tatton WG, Chalmers-Redman RM, Ju WY, Wadia J, Tatton NA. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J Neurol Transm Suppl 1997;49: 245-68.
246. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139-76.
247. Jacobson MD. Apoptosis: Bcl-2-related proteins get connected. Curr Biol 1997;7:277-281.
248. Mattson MP, Barger SW, Furukawa K, et al. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res Rev 1997;23:47-61.
249. Kruman I, Guo Q, Mattson MP. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res 1996;51:293-308.
250. Satoh T, Enokido Y, Aoshima H Uchiyama Y, Hatanaka H. Changes in mitochondrial membrane potential during oxidative stress-induced apoptosis in PC12 cells. J Neurosci Res 1997;50: 413-20.
251. Hortelano S, Dallaporta B, Zamzami N et al. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett 1997;410:373-7.
252. Garland JM, Sondergaard KL, Jolly J. Redox regulation of apoptosis in interleukin-3-dependent haemopoietic cells: absence of alteration in both mitochondrial membrane potential (delta psi (m)) and free radical production during apoptosis induced by IL3. Br J Haematol 1997;99:756-65.
253. Hoyt KR, Gallagher AJ, Hastings TG, Reynolds IJ. Characterization of hydrogen peroxide toxicity in cultured rat forebrain. Neurochem Res 1997;22:333-40.
254. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
255. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275:1129-32.
256. Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett 1998;423:275-80.
257. Susin S, Zamzami N, Castedo M, et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 1996; 186: 25-37.
258. Klivenyi P, Ferrante RJ, Matthews RT et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 1999;5:347-50.
259. Rordorf G, Koroshetz WJ, Bonventre JV. Heat shock protects cultured neurons from glutamate toxicity. Neuron 1991;7:1043-51.
260. Mailhos C, Howard MK, Latchman DS. Heat shock protects neuronal cells from programmed cell death by apoptosis. Neuroscience 1993;55:621-7.
261. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/ APO-1-and staurosporine-induced cell death. J Biol Chem 1996; 271:16510-4.
262. Polla BS, Banzet N, Dall'Ava J, Arrigo AP, Vignola AM. Les mitochondries, carrefour entre vie et mort cellulaire: rôles des protéines de stress et conséquences sur l'inflammation. Médecine/ Sciences 1998;14:18-25.
263. Guenal I, Sidoti-de Fraissc C, Gaumer S, Mignotte. Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogens 1997;15:347-60.
264. Vigh L, Literati PN, Horvath I, et al. Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med 1997:13:1150-4.
265. Hirsch T, Marchetti P, Susin AS, et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997;199:1573-81.
266. Michel PP, Vyas S, Agid Y. Synergistic differentiation by chronic exposure to cyclic AMP and nerve growth factor renders rat phaeochromocytoma PC12 cells totally dependent upon trophic support for survival. Eur J Neurosci 1995:7:251-60.
267. Rubin LL, Gatchalian CL, Rimon G, Brooks SF. The molecular mechanisms of neuronal apoptosis. Curr Opin Neurobiol 1994;4: 696-702.
268. Ross ME. Cell division and the nervous system: regulating the cycle from neural differentiation to death. Trends Neurosci 1996; 19:62-8.
269. Thomaidou D, Mione MC, Cavanagh JF, Parnavelas JG. Apoptosis and its relation to the cell cycle in the developing cerebral cortex. J Neurosci 1997;17:1075-85.
270. Freeman RS, Estus S, Johnson EM Jr. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 1994;12:343-55.
271. Shirvan A, Ziv I, Zilkha-Falb R, Machlyn T, Barzilai A, Melamed E. Expression of cell cycle-related genes during neuronal apoptosis: is there a distinct pattern? Neurochem Res 1998;23: 767-7.
272. Herrup K, Busser JC. The induction of multiple cell cycle events precedes target-related neuronal death. Development 1995;121: 2385-95.
273. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. The retinoblastoma gene product regulates progression through G1 phase of the cell cycle. Cell 1991;67:293-302.
274. Feddersen RM, Clark HB, Yunis WS, Orr HT. In vivo viability of postmitotic Purkinje neurons requires pRb family member function. Mol Cell Neurosci 1995;6:153-67.
275. Trimmer PA, Smith TS, Jung AB, Bennett JP Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneration 1996;5:233-9.
276. Kranenburg O, van der Eb AJ, Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 1996;15: 46-54.
277. Park DS, Farinelli SE, Greene LA. Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J Biol Chem 1996;271: 8161-9.
278. Park DS, Morris EJ, Greene LA, Geller HM. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci 1997;17:1256-70.
279. Maas JW, Horstmann S, Borasio GD, Anneser JM, Shooter EM, Kahle PJ. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors. J Neurochem 1998;70:1401-10.
280. Farinelli SE, Greene LA Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support. J Neurosci 1996;16:1150-62.
281. Lu N, DiCicco-Bloom E. Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc Natl Acad Sci USA 1997;94:3357-62.
282. Michel PP, Agid Y. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J Neurochem 1996;67: 1633-42.
283. Mayo JC, Sainz RM, Uria H, Antolin I, Esteban MM, Rodriguez C. Inhibition of cell proliferation: a mechanism likely to mediate the prevention of neuronal cell death by melatonin. J Pineal Res 1998; 25:12-8.
284. Heintz N. Ataxia telangiectasia: cell signaling, cell death and the cell cycle. Curr Opin Neurol 1996;9:137-40.
285. Roperch JP, Alvaro V, Prieur S, et al. Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression. Nat Med 1998;4:835-8.
286. de la Monte SM, Sohn YK, Ganju N, Wands JR. P53-and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 1998;78:401-11.
287. Nagy Z, Esiri MM, Smith AD. Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol 1997;93:294-300.
288. Vincent I, Jicha G, Rosado M, Dickson DW. Aberrant expression of mitotic Cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 1997;17:3588-98.
289. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998;18:2801-7.
290. Akaneya Y, Takahashi M, Hatanaka H. Selective acid vulnerability of dopaminergic neurons and its recovery by brain-derived neurotrophic factor. Brain Res 1995;704:175-83.
291. Michel PP, Ruberg M, Agid Y. Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem 1997;69:1499-507.
292. Michel PP, Marien M, Ruberg M, Colpaert F, Agid Y. Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes. J Neurochem 1999;72: 2074-82.
293. Mogi M, Harada M, Kondo T, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 1994;180:147-50.
294. Villares J, Faucheux B, Herrero M, et al. 125-I-EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys. Exp Neurol 1998;154:146-56.
295. Bakshi A, Jensen JP, Goldman P, et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome14 and near a transcriptional unit on 18. Cell 1985;4: 899-906.
296. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the Bcl-2 gene in human follicular lymphoma. Science 1985;228: 1440-3.